Abivax shares are trading higher after Truist Securities maintained its Buy rating on the stock and raised its price target from $135 to $15
Abivax shares are trading higher after Truist Securities maintained its Buy rating on the stock and raised its price target from $135 to $155.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.